Related references
Note: Only part of the references are listed.TP53 gain-of-function mutation promotes inflammation in glioblastoma
Seok Won Ham et al.
CELL DEATH AND DIFFERENTIATION (2019)
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Xiaolei Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
IMMUNOTHERAPY Cancer immunotherapy and the value of cure
Joseph C. Del Paggio
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2018)
Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer
Zehang Jiang et al.
TRANSLATIONAL ONCOLOGY (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity
Zdenek Andrysik et al.
GENOME RESEARCH (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Genome-wide in vivo screen identifies novel host regulators of metastatic colonization
Louise van der Weyden et al.
NATURE (2017)
Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
Mirjana Efremova et al.
FRONTIERS IN IMMUNOLOGY (2017)
Clinical Study on the Medical Value of Combination Therapy Involving Adoptive Immunotherapy and Chemotherapy for Stage IV Colorectal Cancer (COMVI Study)
Yoichiro Yoshida et al.
ANTICANCER RESEARCH (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer
Anton Safonov et al.
CANCER RESEARCH (2017)
Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity
Gang Guo et al.
CANCER RESEARCH (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Genomic Approaches to Understanding Response and Resistance to Immunotherapy
David A. Braun et al.
CLINICAL CANCER RESEARCH (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
Jiandong Chen
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Characterization of cytokinome landscape for clinical responses in human cancers
Henry Sung-Ching Wong et al.
ONCOIMMUNOLOGY (2016)
Emerging roles of p53 and other tumour-suppressor genes in immune regulation
Cesar Munoz-Fontela et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Widespread parainflammation in human cancer
Dvir Aran et al.
GENOME BIOLOGY (2016)
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
Maarten P. G. Massink et al.
BMC CANCER (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Prognostic and predictive immune gene signatures in breast cancer
Davide Bedognetti et al.
CURRENT OPINION IN ONCOLOGY (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A p53-regulated immune checkpoint relevant to cancer
Laurence Zitvogel et al.
SCIENCE (2015)
ppcor: An R Package for a Fast Calculation to Semi-partial Correlation Coefficients
Seongho Kim
COMMUNICATIONS FOR STATISTICAL APPLICATIONS AND METHODS (2015)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L. Bracci et al.
CELL DEATH AND DIFFERENTIATION (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Tumor STAT1 Transcription Factor Activity Enhances Breast Tumor Growth and Immune Suppression Mediated by Myeloid-derived Suppressor Cells
Laura M. Hix et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1
Bei Wang et al.
NATURE COMMUNICATIONS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Maria Shatz et al.
CANCER RESEARCH (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
p53 Binds to Estrogen Receptor 1 Promoter in Human Breast Cancer Cells
Mozhgan Rasti et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
Sonja Textor et al.
CANCER RESEARCH (2011)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Otavia L. Caballero et al.
CANCER SCIENCE (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
Luiz Gonzaga Almeida et al.
NUCLEIC ACIDS RESEARCH (2009)
Tumor Suppressive Functions of p53
Jack T. Zilfou et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
A chemical method for fast and sensitive detection of DNA synthesis in vivo
Adrian Salic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors
Stephanie Renaud et al.
NUCLEIC ACIDS RESEARCH (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation of estrogen receptor-α expression by the tumor suppressor gene p53 in MCF-7 cells
SV Angeloni et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection
BG Dorner et al.
JOURNAL OF IMMUNOLOGY (2004)
STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis
PA Townsend et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer
J Overgaard et al.
ACTA ONCOLOGICA (2000)
Share Paper
